Mohamed Eltahir

Mohamed Eltahir is a highly experienced medical professional currently serving as Chief Resident and Pathology Resident at Baylor College of Medicine since July 2021. Concurrently, Mohamed holds a position as a Postdoctoral Researcher at Uppsala University, focusing on tumor immunology and developing novel cancer immunotherapeutics. In addition, Mohamed is a co-founder of Strike Pharma AB since December 2020. Previous experience includes serving as a Graduate Research Assistant and Project Student at Karolinska Institutet, and as an Intern Physician at King Saud Medical City. Mohamed obtained a Master’s Degree in Biomedicine from Uppsala University and a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Khartoum.